Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Dabigatran or its salts or derivatives

including but not limited to dabigatran etexilate

I DEC / 13
Dabrafenib or its salts I DEC / 13
Dacarbazine I DEC / 13
Daclatasvir or its salts I OCT / 15
Daclizumab I DEC / 13
Daclizumab beta I FEB / 17
Dacomitinib or its salts I MAR / 19
Dactinomycin I DEC / 13
Dalbavancin or its salts I OCT / 18
Dalfopristin or its salts I DEC / 13
Dalteparin or its salts I DEC / 13
Danaparoid or its salts or derivatives I DEC / 13
Danazol I DEC / 13
Danofloxacin or its salts I DEC / 13
Danthron III SEP / 98
Dantrolene or its salts I DEC / 13
Dapagliflozin or its derivatives I MAR / 15
Dapiprazole or its salts I DEC / 13
Daptomycin I DEC / 13
Daratumumab I AUG / 16
Darifenacin or its salts I DEC / 13
Darolutamide I JUL / 20
Darunavir I DEC / 13
Dasabuvir or its salts I MAR / 15
Dasatanib I DEC / 13
Daunorubicin or its salts I DEC / 13
Debrisoquin or its salts I DEC / 13
Decitabine or its salts I FEB / 19
Deferasirox I DEC / 13
Deferiprone or its derivatives I MAR / 15
Deferoxamine or its salts I DEC / 13
Defibrotide or its salts or derivatives I SEP / 17
Degarelix or its salts or derivatives I DEC / 13
Dehydrocholic acid and its salts III SEP / 98
Delavirdine or its salts I DEC / 13
Denosumab I DEC / 13
Deoxycholic acid or its salts

when used in an injectable form

I OCT / 15
Deracoxib I DEC / 13
Derquantel or its salts

for veterinary use

I AUG / 16
Deserpidine or its alkaloids or salts I DEC / 13
Desflurane I DEC / 13
Desipramine or its salts I DEC / 13
Desloratadine and its salts and preparations. in products marketed for paediatric use - under 12 years of age III SEP / 05
Desloratadine and its salts and preparations.

in products marketed for adult use - 12 years and older

U SEP / 05
Desmopressin or its salts I DEC / 13
Desoxyribonuclease [pancreatic dornase] II SEP / 98
Desvenlafaxine or its salts

including but not limited to desvenlafaxine succinate

I DEC / 13
Detomidine or its salts I DEC / 13
Dexbrompheniramine and its salts III SEP / 98
Dexchlorpheniramine and its salts III SEP / 98
Dexrazoxane or its salts I DEC / 13
Dextromethorphan and its salts except in oral dosage forms in package sizes containing no more than 300mg DM base or 409.3 DM hydrobromide III AUG / 02
Dextromethorphan and its salts. in oral dosage forms in package sizes containing no more than 300 mg DM base or 409.3 DM hydrobromide U AUG / 02
Dextrose sclerosing agents II SEP / 98
Dextrose injection concentrated solutions for parenteral injection I JAN / 03
Diazoxide or its salts I DEC / 13
Dibotermin alfa

for veterinary use

I FEB / 14
Dichloroacetic acid I DEC / 13
Diclofenac diethylamine when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days - in concentrations greater than 1.16% and less than or equal to 2.32% - in package sizes containing greater than 2.6g of diclofenac diethylamine II AUG / 14
Diclofenac diethylamine.

when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days - in concentrations greater than 1.16% and less than or equal to 2.32% - in package sizes containing no more than 2.6g of diclofenac diethylamine

III AUG / 14
Diclofenac diethylamine..

when sold as a single medicinal ingredient for topical use on the skin in concentrations of not more than 1.16% for not more than 7 days

U AUG / 14
Diclofenac or its salts

including (but not limited to): diclofenac diethylamine, diclofenac sodium, diclofenac potassium, except when sold as a single medicinal ingredient for topical use on the skin in a concentration equivalent to 2% or less of diclofenac for not more than 7 days

I AUG / 14
Dicyclomine and its salts except for topical use and lozenges II SEP / 98
Didanosine or its salts or derivatives I DEC / 13
Diethylbromacetamide I DEC / 13
Diethylcarbamazine or its salts I DEC / 13
Diethylpropion and any salt thereofC I JUN / 02
Diethylstilbestrol or its salts or derivatives I DEC / 13
Difloxacin or its salts or derivatives I DEC / 13
Diflunisal or its salts I DEC / 13
Digitalis lanata or its glycosides I DEC / 13
Digitalis purpurea or its glycosides I DEC / 13
Digoxin immune Fab

ovine

I DEC / 13
Dihydroquinidine and its salts except phenylbarbiturate II SEP / 98
Dihydrostreptomycin or its salts or derivatives

For human use

I DEC / 18
Dihydrotachysterol

for human use

I DEC / 13
Diiodohydroxyquin

except in preparations for topical use on the skin

I DEC / 13
Diiodohydroxyquin

for topical use on the skin

II SEP / 98
Diltiazem or its salts I DEC / 13
Dimenhydrinate and its salts for parenteral use II SEP / 98
Dimenhydrinate and its salts. for oral or rectal use [Note: Pharmacists are advised that in areas where there is evidence of abuse or particular concern about abuse, dimenhydrinate products should not be located in a self-selection area of the pharmacy]. III APR / 99
Dimercaprol I DEC / 13
Dimethothiazine III SEP / 98
Dimethyl sulfoxide

For human use, when sold for the treatment of interstitial cystitis or scleroderma

I DEC / 13
Dimethyl sulfoxide

For veterinary use

I DEC / 13
Dimethylfumarate I DEC / 13
Dimeticone 100 cSt solution 50% w/w for topical use in the treatment of head lice III JAN / 13
2,4- Dinitrophenol or its salts or derivatives I DEC / 13
Dinutuximab I DEC / 18
Diperodon and its salts except for topical use II SEP / 98
Diphenhydramine and its salts and preparations for parenteral use II SEP / 98
Diphenhydramine and its salts and preparations. except for parenteral or topical use III SEP / 98
Diphenhydramine and its salts and preparations.. for topical use in concentrations of greater than 2% II MAY / 06
Diphenhydramine and its salts and preparations... for topical use in concentrations of 2% or less when sold in containers of greater than 300 mg of diphenhydramine hydrochloride III MAY / 06
Diphenhydramine and its salts and preparations... for topical use in concentrations of 2% or less when sold in containers of 300 mg or less of diphenhydramine hydrochloride U OCT / 09
Diphenidol or its salts I DEC / 13
Diphenylhydantoin (phenytoin) or its salts I SEP / 98
Diphenylpyraline III SEP / 98
Diphtheria toxoid II DEC / 98
Dipivefrin or its salts I DEC / 13

136 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act